AAAAAA
Results: 1-25/41
Authors:
Avorn, J
Citation: J. Avorn, Unhealthy ageing: functional and socioeconomic impact, EUR H J SUP, 3(N), 2001, pp. N3-N5
Authors:
Glynn, RJ
Knight, EL
Levin, R
Avorn, J
Citation: Rj. Glynn et al., Paradoxical relations of drug treatment with mortality in older persons, EPIDEMIOLOG, 12(6), 2001, pp. 682-689
Authors:
van Eijk, MEC
Avorn, J
Porsius, AJ
de Boer, A
Citation: Mec. Van Eijk et al., Reducing prescribing of highly anticholinergic antidepressants for elderlypeople: randomised trial of group versus individual academic detailing, BR MED J, 322(7287), 2001, pp. 654-657
Authors:
Wang, PS
Walker, AM
Tsuang, MT
Orav, EJ
Levin, R
Avorn, J
Citation: Ps. Wang et al., Finding incident breast cancer cases through US claims data and a state cancer registry, CANC CAUSE, 12(3), 2001, pp. 257-265
Authors:
Wang, PS
Walker, AM
Tsuang, MT
Orav, EJ
Levin, R
Avorn, J
Citation: Ps. Wang et al., Antidepressant use and the risk of breast cancer: A non-association, J CLIN EPID, 54(7), 2001, pp. 728-734
Authors:
Ganz, DA
Avorn, J
Citation: Da. Ganz et J. Avorn, Untitled - Reply, J GEN INT M, 16(5), 2001, pp. 347-347
Authors:
Solomon, DH
Stone, PH
Glynn, RJ
Ganz, DA
Gibson, CM
Tracy, R
Avorn, J
Citation: Dh. Solomon et al., Use of risk stratification to identify patients with unstable angina likeliest to benefit from an invasive versus conservative management strategy, J AM COL C, 38(4), 2001, pp. 969-976
Authors:
Berard, A
Solomon, DH
Avorn, J
Citation: A. Berard et al., Patterns of drug use in rheumatoid arthritis - Drs. Berard, et al reply, J RHEUMATOL, 28(6), 2001, pp. 1465-1465
Authors:
Winkelmayer, WC
Glynn, RJ
Levin, R
Owen, WF
Avorn, J
Citation: Wc. Winkelmayer et al., Determinants of delayed nephrologist referral in patients with chronic kidney disease, AM J KIDNEY, 38(6), 2001, pp. 1178-1184
Authors:
Knight, EL
Bohn, RL
Wang, PS
Glynn, RJ
Mogun, H
Avorn, J
Citation: El. Knight et al., Predictors of uncontrolled hypertension in ambulatory patients, HYPERTENSIO, 38(4), 2001, pp. 809-814
Authors:
van Eijk, MEC
Krist, LFG
Avorn, J
Porsius, A
de Boer, A
Citation: Mec. Van Eijk et al., Do the research goal and databases match? A checklist for a systematic approach, HEALTH POLI, 58(3), 2001, pp. 263-274
Authors:
Avorn, J
Citation: J. Avorn, Improving drug use in elderly patients - Getting to the next level, J AM MED A, 286(22), 2001, pp. 2866-2868
Authors:
Winkelmayer, WC
Glynn, RJ
Levin, R
Owen, W
Avorn, J
Citation: Wc. Winkelmayer et al., Late referral and modality choice in end-stage renal disease, KIDNEY INT, 60(4), 2001, pp. 1547-1554
Authors:
Solomon, DH
Van Houten, L
Glynn, RJ
Baden, L
Curtis, K
Schrager, H
Avorn, J
Citation: Dh. Solomon et al., Academic detailing to improve use of broad-spectrum antibiotics at an academic medical center, ARCH IN MED, 161(15), 2001, pp. 1897-1902
Authors:
Field, TS
Gurwitz, JH
Avorn, J
McCormick, D
Jain, S
Eckler, M
Benser, M
Bates, DW
Citation: Ts. Field et al., Risk factors for adverse drug events among nursing home residents, ARCH IN MED, 161(13), 2001, pp. 1629-1634
Authors:
Knight, EL
Avorn, J
Citation: El. Knight et J. Avorn, Quality indicators for appropriate medication use in vulnerable elders, ANN INT MED, 135(8), 2001, pp. 703-710
Authors:
Wang, PS
Bohn, RL
Glynn, RJ
Mogun, H
Avorn, J
Citation: Ps. Wang et al., Hazardous benzodiazepine regimens in the elderly: Effects of half-life, dosage, and duration on risk of hip fracture, AM J PSYCHI, 158(6), 2001, pp. 892-898
Authors:
Schneeweiss, S
Seeger, JD
Maclure, M
Wang, PS
Avorn, J
Glynn, RJ
Citation: S. Schneeweiss et al., Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data, AM J EPIDEM, 154(9), 2001, pp. 854-864
Authors:
Avorn, J
Citation: J. Avorn, Post-modern drug evaluation - The deconstruction of evidence-based regulation, PHARMACOECO, 18, 2000, pp. 15-20
Authors:
Bohn, RL
Gurwitz, JH
Yeomans, SM
Glynn, RJ
Pasquale, LR
Walker, AM
Avorn, J
Citation: Rl. Bohn et al., Which patients are treated for glaucoma? An observational analysis, J GLAUCOMA, 9(1), 2000, pp. 38-44
Authors:
Wang, PS
Walker, A
Tsuang, M
Orav, EJ
Levin, R
Avorn, J
Citation: Ps. Wang et al., Strategies for improving comorbidity measures based on Medicare and Medicaid claims data, J CLIN EPID, 53(6), 2000, pp. 571-578
Authors:
van Eijk, MEC
Bahri, P
Dekker, G
Herings, RMC
Porsius, A
Avorn, J
de Boer, A
Citation: Mec. Van Eijk et al., Use of prevalence and incidence measures to describe age-related prescribing of antidepressants with and without anticholinergic effects, J CLIN EPID, 53(6), 2000, pp. 645-651
Authors:
Ganz, DA
Glynn, RJ
Mogun, H
Knight, EL
Bohn, RL
Avorn, J
Citation: Da. Ganz et al., Adherence to guidelines for oral anticoagulation after venous thrombosis and pulmonary embolism, J GEN INT M, 15(11), 2000, pp. 776-781
Authors:
Knight, EL
Glynn, RJ
Levin, R
Ganz, DA
Avorn, J
Citation: El. Knight et al., Failure of evidence-based medicine in the treatment of hypertension in older patients, J GEN INT M, 15(10), 2000, pp. 702-709
Authors:
Berard, A
Solomon, DH
Avorn, J
Citation: A. Berard et al., Patterns of drug use in rheumatoid arthritis, J RHEUMATOL, 27(7), 2000, pp. 1648-1655